Duran N - Search Results

1

Editorial: Lipid Nanoparticles as a Novel Strategy to Deliver Bioactive Molecules.

Talevi A, Duran N, Castro GR. Talevi A, et al. Among authors: duran n. Front Chem. 2021 Mar 4;9:655480. doi: 10.3389/fchem.2021.655480. eCollection 2021. Front Chem. 2021. PMID: 33748079 Free PMC article. No abstract available.

2

Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers.

Muraca G, Berti IR, Sbaraglini ML, Fávaro WJ, Durán N, Castro GR, Talevi A. Muraca G, et al. Among authors: duran n. Front Chem. 2020 Nov 26;8:601151. doi: 10.3389/fchem.2020.601151. eCollection 2020. Front Chem. 2020. PMID: 33324615 Free PMC article. Review.

3

Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity.

Rivero Berti I, Rodenak-Kladniew BE, Katz SF, Arrua EC, Alvarez VA, Duran N, Castro GR. Rivero Berti I, et al. Among authors: duran n. Front Chem. 2022 Jul 7;10:914126. doi: 10.3389/fchem.2022.914126. eCollection 2022. Front Chem. 2022. PMID: 35873038 Free PMC article.

4

Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.

Islan GA, Tornello PC, Abraham GA, Duran N, Castro GR. Islan GA, et al. Among authors: duran n. Colloids Surf B Biointerfaces. 2016 Jul 1;143:168-176. doi: 10.1016/j.colsurfb.2016.03.040. Epub 2016 Mar 15. Colloids Surf B Biointerfaces. 2016. PMID: 27003467

5

Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.

Rodenak-Kladniew B, Islan GA, de Bravo MG, Durán N, Castro GR. Rodenak-Kladniew B, et al. Among authors: duran n. Colloids Surf B Biointerfaces. 2017 Jun 1;154:123-132. doi: 10.1016/j.colsurfb.2017.03.021. Epub 2017 Mar 9. Colloids Surf B Biointerfaces. 2017. PMID: 28334689

6

Development and tailoring of hybrid lipid nanocarriers.

Islan GA, Cacicedo ML, Rodenak-Kladniew B, Duran N, Castro GR. Islan GA, et al. Among authors: duran n. Curr Pharm Des. 2017 Nov 14. doi: 10.2174/1381612823666171115110639. Online ahead of print. Curr Pharm Des. 2017. PMID: 29141536

7

Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties.

Rodenak-Kladniew B, Scioli Montoto S, Sbaraglini ML, Di Ianni M, Ruiz ME, Talevi A, Alvarez VA, Durán N, Castro GR, Islan GA. Rodenak-Kladniew B, et al. Among authors: duran n. Int J Pharm. 2019 Oct 5;569:118575. doi: 10.1016/j.ijpharm.2019.118575. Epub 2019 Jul 26. Int J Pharm. 2019. PMID: 31356956

8

Patents on Violacein: A Compound with Great Diversity of Biological Activities and Industrial Potential.

Durán N, Fávaro WJ, Brocchi M, Justo GZ, Castro GR, Durán M, Nakazato G. Durán N, et al. Among authors: duran m. Recent Pat Biotechnol. 2021 Oct 4;15(2):102-111. doi: 10.2174/2213476X07666201221111655. Recent Pat Biotechnol. 2021. PMID: 33349223 Review.

9

Prodigiosin: a promising biomolecule with many potential biomedical applications.

Islan GA, Rodenak-Kladniew B, Noacco N, Duran N, Castro GR. Islan GA, et al. Among authors: duran n. Bioengineered. 2022 Jun;13(6):14227-14258. doi: 10.1080/21655979.2022.2084498. Bioengineered. 2022. PMID: 35734783 Free PMC article. Review.

10

Nanodevices for the immobilization of therapeutic enzymes.

Bosio VE, Islan GA, Martínez YN, Durán N, Castro GR. Bosio VE, et al. Among authors: duran n. Crit Rev Biotechnol. 2016;36(3):447-64. doi: 10.3109/07388551.2014.990414. Epub 2015 Feb 2. Crit Rev Biotechnol. 2016. PMID: 25641329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page